Compare Kaltura Inc (KLTR) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kaltura Inc vs McKesson Corporation — how do they compare? Kaltura Inc trades at $1.32 (market cap $199.08M), while McKesson Corporation trades at $938.84 (market cap $108.46B). The key difference: McKesson Corporation is far larger — about 544.8× Kaltura Inc's market cap, and McKesson Corporation pays a 0.4% dividend while Kaltura Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kaltura Inc for 21 Days and McKesson Corporation for 74 Days on average.
| KLTR | MCK | |
|---|---|---|
Market Cap | $199.08M | $108.46B |
Volume | 175,927 | 712,607 |
Sector | Technology | Health |
52-Week High | $1.89 | $995.69 |
52-Week Low | $1.08 | $725.17 |
Typical Hold Time | 21 Days | 74 Days |
Enterprise Value | $211.29M | $115.00B |
Dividend Yield | — | 0.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
KLTR trades at $1.305, down 1.88% for the day, with a bearish technical signal from moving averages. The company reported revenue of $180.85M for 2025 but remains unprofitable with a net loss of $12.07M, though losses have narrowed significantly since 2022. Recent news highlights include winning the 2026 Digiday Technology Award and being named a leader by Gartner in AI for video platform services.
The outlook is mixed: analyst consensus leans buy (44% buy ratings), and the company shows improving financial trends, but high valuation ratios and persistent net losses present risks. Key catalysts include the commercial rollout of AI products, while execution risks and competitive pressures remain concerns for investors.
McKesson (MCK) trades at $930.25, up 2.19% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $9.93 surpassing the $9.56 estimate. Revenue growth is robust, reaching $359.05B in 2025, though net margins are thin at 1.12%. Recent news highlights a key distribution extension with CVS Health through 2032, reinforcing long-term visibility.
The outlook is positive, driven by operational strength and strategic partnerships, but investors face risks from margin pressure and drug pricing uncertainty. With 81% of analysts rating it Buy and a consensus target of $956.43, the stock offers upside, though high RSI levels suggest near-term caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kaltura Inc
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments: (i) Enterprise, Education, and Technology (EE&T)
Read more on KLTR →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
